Faı̈ez Zannad

8 ta ish

University of Lorraine

1. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

   Milton Packer, Stefan D. Anker, Javed Butler +36

   Maqola20208 iqtibos

   ABIABI:AkademIndex/2026.other.282518

2. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

   Faı̈ez Zannad, John J.V. McMurray, Henry Krum +6

   Maqola20105 iqtibos

   ABIABI:AkademIndex/2026.other.295788

3. 2013 ESH/ESC Guidelines for the management of arterial hypertension

   Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz +22

   Maqola20135 iqtibos

   ABIABI:AkademIndex/2026.other.434885

4. 2013 ESH/ESC Guidelines for the management of arterial hypertension

   Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz +89

   MaqolaOAOchiq kirish20134 iqtibos

   ABIABI:AkademIndex/2026.other.091076

5. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

   Bertram Pitt, Faı̈ez Zannad, Willem J. Remme +5

   Maqola19993 iqtibos

   ABIABI:AkademIndex/2026.other.295803

6. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

   Bertram Pitt, Willem J. Remme, Faı̈ez Zannad +7

   Maqola20033 iqtibos

   ABIABI:AkademIndex/2026.other.721690

7. Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

   Scott D. Solomon, John J.V. McMurray, Inder S. Anand +31

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.295865

8. Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure

   Karl Swedberg, Faı̈ez Zannad, John J.V. McMurray +5

   Maqola20122 iqtibos

   ABIABI:AkademIndex/2026.other.613463